Aditya Birla Sun Life MF is launching Aditya Birla Sun Life Pharma & Healthcare Fund, an open-ended sectoral equity scheme.
The fund aims to capture the opportunities in the pharma and healthcare services space. Along with core pharma, the fund will also look at other large opportunities in sectors like hospitals and diagnostics. Moreover, the fund also has the option to invest in innovators, patent holders & specialty instrument makers in global markets.
Commenting on the launch, A. Balasubramanian, CEO, Aditya Birla Sun Life AMC Ltd, in a press release said, “The sector has been a long term outperformer over a 10 year period, except in the past 2-3 years. The underperformance of the sector in the last 3 years was due to compliance issues coming from abroad and pricing pressures. We believe this risk is already factored in the prices, given the strong balance sheets and export potential of companies in the sector. Poised for a strong rebound, there is opportunity in the coming cycle to take position given the attractive valuations and the potential growth in the sector”.
Dhaval Shah, Fund Manager and Senior Analyst, Aditya Birla Sun Life MF will manage the fund. The benchmark index for the fund is S&P BSE Healthcare TRI (Total Return Index).
